ecteinascidin 743 has been researched along with tryptoline in 1 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (tryptoline) | Trials (tryptoline) | Recent Studies (post-2010) (tryptoline) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 222 | 1 | 69 |
| Protein | Taxonomy | ecteinascidin 743 (IC50) | tryptoline (IC50) |
|---|---|---|---|
| Vif | Human immunodeficiency virus 1 | 84.25 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 84.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ji, M; Liu, Z; Lu, X; Pan, X; Xiao, Z; Yang, Y | 1 |
1 other study(ies) available for ecteinascidin 743 and tryptoline
| Article | Year |
|---|---|
Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
Topics: Antineoplastic Agents; Carbolines; Dioxoles; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2017 |